Silencing of Inducible Immunoproteasome Subunit Expression by Chemically Modified SiRNA and ShRNA
Overview
Authors
Affiliations
Overexpression of inducible subunits of immunoproteasome is related to pathogenesis of some chronic diseases. Specific inhibition of the immunosubunits may be used for the treatment of these diseases and RNA interference is one of the potent methods used in this area. We designed 2'-O-methyl modified siRNAs with selectively protected nuclease-sensitive sites, which efficiently silence LMP2, LMP7, and MECL-1 genes expression. To provide stable long-lasting inhibition of target genes, short-hairpin RNAs (shRNA) expressed by lentiviral vectors were constructed. Our results demonstrated that chemically modified siRNAs inhibited the expression of target genes with similar efficiency or with efficiency exceeding that of corresponding shRNAs and provide silencing effect for 5 days.
Pomatto L, Cline M, Woodward N, Pakbin P, Sioutas C, Morgan T Free Radic Biol Med. 2018; 121:86-97.
PMID: 29709705 PMC: 5987225. DOI: 10.1016/j.freeradbiomed.2018.04.574.
Hong S, Zhang M, Zhang M, Yu Y, Chen J, Zhang X Drug Deliv. 2018; 25(1):576-584.
PMID: 29461120 PMC: 6058603. DOI: 10.1080/10717544.2018.1440667.
Hu B, Meng X, Zhang Y, Hossain M, Wu L, Zhang Y Oncol Rep. 2018; 39(4):1640-1648.
PMID: 29393483 PMC: 5868399. DOI: 10.3892/or.2018.6237.